Pfizer's Bivalent Omicron Booster Will Be Available for Children Ages 6 to 4

FDA authorized use of Pfizer's bivalent omicron booster shot for children between the ages of six months and four years old. Drug companies will pay back Medicare through rebates in order to make up the difference. The drugs include AVVs, hugely popular rheumatoid arthritis drug, Humira,. Also included are drugs to treat fungal infections, testosterone replacement therapies, and some cancer treatments. CMS said that beneficiaries could drop by as much as $390 per dose depending on coverage.